SGLT2 Inhibitors place in therapy More than just an anti glycemic agent

2:45 pm - 3:45 pm
Off Campus
Bridget O’Donnell, PharmD

SGLT2 Inhibitors place in therapy 

More than just an anti glycemic agent

Schedule:      December 3, 2021, 2:45 to 3:45pm Live Burlington, MA

                       Enduring session Release December 3, 2021 Close January 3, 2022

Audience:      Accredited for Pharmacists

                       Other interested health care professionals welcome

Credits:         1 Contact Hour of Knowledge based

                       1.0 CEUs will be awarded under the provider

Presenter(s): Bridget O’Donnell, PharmD, PGY1 Pharmacy Resident, Lahey Hospital & Medical Center

No charge for CE

Learning Objectives for Pharmacists:

After attending this program, participants will be able to:

  1. Describe key considerations affecting SGLT2 inhibitor use such as patient selection, dosing, adverse effects and monitoring parameters
  2. Identify data from studies that support SGLT2 inhibitors’ expanding place in therapy for a variety of diseases
  3. Use knowledge of data regarding SGLT2 inhibitors to make a patient specific recommendation based on a patient case

Requirements for Receiving CE Credit:

  • Successful completion of post presentation questions
  • Participation at live program
  • Complete program online evaluation form
  • NABP #

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.